BioNxt Solutions Inc. to Settle Debt with Share Issuance
vancouver,BC – November 21,2023 – BioNxt Solutions Inc. announced today that it intends to settle outstanding debt through the issuance of shares. The company plans to issue up to 1,428,571 common shares to creditors to extinguish approximately $71,428.57 in debt.
The shares will be issued at a price of $0.05 per share.This debt settlement is subject to the final approval of the Canadian Securities Exchange (CSE).
BioNxt cautions that the shares being issued in this debt settlement have not been, and will not be, registered under the U.S. Securities Act of 1933 and may not be offered or sold in the United States unless registered or exempt from registration requirements, and in compliance with applicable state securities laws.
The company’s press release also includes forward-looking statements regarding the receipt of required regulatory approvals. BioNxt emphasizes that actual results may differ materially from those currently anticipated, and readers should not place undue reliance on these statements. The company disclaims any obligation to update these forward-looking statements except as required by law.
Disclaimer: The CSE has not accepted responsibility for the adequacy or accuracy of this release.
Source: bionxt Solutions Inc. – originally published on ACCESS Newswire.
